{"id":"cital","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[{"effect":"Ejaculation disorder","drugRate":"","severity":"common","organSystem":""},{"effect":"Nausea","drugRate":"4%","severity":"common","organSystem":""},{"effect":"Insomnia","drugRate":"3%","severity":"common","organSystem":""},{"effect":"Dizziness","drugRate":"2%","severity":"common","organSystem":""},{"effect":"Somnolence","drugRate":"2%","severity":"common","organSystem":""},{"effect":"Asthenia","drugRate":"1%","severity":"common","organSystem":""},{"effect":"Dry mouth","drugRate":"1%","severity":"common","organSystem":""},{"effect":"Vomiting","drugRate":"1%","severity":"common","organSystem":""},{"effect":"Agitation","drugRate":"1%","severity":"common","organSystem":""}],"contraindications":["Acute nephropathy","Bipolar disorder","Blood coagulation disorder","Bradycardia","Chronic heart failure","Congenital long QT syndrome","Disease of liver","Epilepsy","Heart disease","Hypokalemia","Hypomagnesemia","Hyponatremia","Myocardial infarction in recovery phase","Neuroleptic malignant syndrome","Poor metabolizer due to cytochrome p450 CYP2C19 variant","Prolonged QT interval","Serotonin syndrome","Suicidal thoughts","Syndrome of inappropriate vasopressin secretion","Torsades de pointes","Upper gastrointestinal hemorrhage"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[{"effect":"Suicidal thoughts and behaviors","drugRate":"","severity":"serious"},{"effect":"QT-prolongation and torsade de pointes","drugRate":"","severity":"serious"},{"effect":"Serotonin syndrome","drugRate":"","severity":"serious"},{"effect":"Increased risk of bleeding","drugRate":"","severity":"serious"},{"effect":"Activation of mania or hypomania","drugRate":"","severity":"serious"},{"effect":"Seizures","drugRate":"","severity":"serious"},{"effect":"Angle-closure glaucoma","drugRate":"","severity":"serious"},{"effect":"Hyponatremia","drugRate":"","severity":"serious"},{"effect":"Discontinuation syndrome","drugRate":"","severity":"serious"},{"effect":"Hypersensitivity reactions","drugRate":"","severity":"serious"}]},"trials":[],"_chembl":null,"aliases":["Paramol"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":{"setId":"351ca54b-0eb6-4e93-8ab4-82fb18dcc9e1","title":"CITALOPRAM HYDROBROMIDE TABLET, FILM COATED [ST MARYS MEDICAL PARK PHARMACY]"},"ecosystem":[],"mechanism":{"target":"Solute carrier family 22 member 1, 5-hydroxytryptamine receptor 2A, 5-hydroxytryptamine receptor 2B"},"_scrapedAt":"2026-03-28T06:00:44.224Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Depressive disorder","diseaseId":"depressive-disorder","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Generalized anxiety disorder","diseaseId":"generalized-anxiety-disorder","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Major depressive disorder","diseaseId":"major-depressive-disorder","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT03423329","phase":"NA","title":"Effectiveness of Buccal Infiltration During Vital Pulpotomy After Administering Two Analgesic Premedications","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2018-01-20","conditions":"Anesthesia, Local","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":8,"therapeuticAreas":["Neuroscience"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Cital","genericName":"Cital","companyName":"Ain Shams University","companyId":"ain-shams-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":false,"indications":true,"safety":true,"trials":true,"score":3}}